An Incisive, In-depth Analysis on the Hepatitis B Diagnostic Test Market
This study offers a comprehensive, 360 degree analysis on the Hepatitis B Diagnostic Test market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Hepatitis B Diagnostic Test market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Increasing prevalence of Hepatitis B around the world is expected to boost the global Hepatitis B diagnostic tests market
Hepatitis B is a potentially life threatening infection and has become a major healthcare problem all over the world. As per the data provided by WHO, an estimated 257 million people are living with hepatitis B viral infection. In the year 2015, hepatitis resulted in 887,000 deaths, mostly from complications such as hepatocellular carcinoma and cirrhosis. The prevalence of hepatitis B is highest in the Western Pacific and African regions where 6.2% and 6.1% respectively of the adult population is infected. Hepatitis B can cause chronic infection and pose a high risk of mortality. It is estimated that 80-90% of the infants infected with hepatitis B during first year of life develop chronic infections.
There is an increased prevalence of hepatitis B due to the exploding urbanization and environmental changes due to a changing lifestyle. This situation creates a huge opportunity for hepatitis B diagnostic test manufacturers. In addition, a rising awareness due to the initiatives taken by governments and non-profit organizations is likely to fuel the growth of the global hepatitis B diagnostic test market. There is a growing awareness about the need for early detection of hepatitis B infections and this also is likely to fuel the growth of the market. Market penetration of point-of-care tests due to the increasing awareness is also boosting the market growth, especially in developed countries.
As per our assessment, the global hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 650 Mn in 2017 and is likely to reach a valuation of nearly US$ 1,200 Mn in 2017 and account for a CAGR of 6.3% during the assessment period 2017-2027.
Increasing prevalence of acute cases of Hepatitis B is expected to drive the market in North America
The prevalence of acute hepatitis cases is high in North America due to the exposure to blood or body fluids of an infected person, reuse of injections, unscreened blood transfusion or sexual contact with an infected person. According to CDC, the number of reported cases of hepatitis B increased from 0.3% between 2011 and 2012 to 20.7%, i.e. 3,370 cases in 2015. Chronic cases of hepatitis B in the United States were estimated to be 850,000. However, other sources put the figure to be more than 2.2 million.
Diagnosis is the first crucial step for getting the recommended care and treatment for the patients suffering from hepatitis B. Due to such reasons, CDC and the U.S. government have taken initiatives to screen the hepatitis B infection in early stages. CDC and USPSTF have recommended HBV testing for the people travelling to the United States from endemic regions in order to prevent the outbreak of hepatitis B.
Global Hepatitis B Diagnostic Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Region
As per the report figures, the North America hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 140 Mn in 2017 and is expected to reach a valuation of nearly US$ 210 Mn in 2027, exhibiting a CAGR of 4.6% during the assessment period of 2017-2027. The Middle East and Africa hepatitis B diagnostic test market was estimated to be valued at nearly US$ 130 Mn in 2017 and is anticipated to reach a valuation of nearly US$ 250 Mn in 2027, accounting for a CAGR of 6.9% during the period of forecast.
This report tracks the global hepatitis B diagnostic tests market and presents the value forecast for this market for a period of 10 years. According to WHO, Hepatitis B is an infectious disease caused by a viral infection that attacks the liver and can cause both acute and chronic infections. This viral infection is transferred through contact with blood or other fluids of an infected person such as semen, vaginal discharge, breast milk, and saliva.
A clear-cut report structure to make the report on global Hepatitis B diagnostic tests lucid and up-to-date
In order to have an ease of understanding and for the better organization of the report, the report on global hepatitis B diagnostic tests market has been divided into four distinct parts. The first part of the report contains the introduction section that has the executive summary of the report along with the market taxonomy and the definition of the hepatitis B diseases and the market viewpoint. This valuable section of the report also contains information on global hepatitis B diagnostic tests market: pricing analysis by hepatitis B surface antigen tests, 2016 & 2027. Besides this, the introduction section of the report also contains information on the macro-economic factors affecting the global hepatitis B diagnostic tests market and presents the opportunities available in this market. Also, the value chain analysis of the global hepatitis B diagnostic tests market is given.
The second part of the report contains the regional hepatitis B diagnostic tests market analysis and the regions are chosen as per the market taxonomy. In this section of the report, besides the regional market numbers, there is detailed information given on the regional drivers, restraints and trends that are operating in the hepatitis B diagnostic tests market. The last part of the report contains the global hepatitis B diagnostic tests market analysis and forecast by product type, end-user and region. This section of the report contains important market numbers in the form of market attractiveness index, incremental dollar opportunity and basis point share analysis.
Competition landscape section is invaluable both for established players and new entrants
Another part of the report features the competition landscape of the global hepatitis B diagnostic tests market and has information on the key players operating in this market. The competition landscape contains detailed information on the important companies operating in the global hepatitis B diagnostic tests market in the form of company description, product overview, key developments, strategic overview and key financials of each of the featured companies along with the SWOT analysis of the companies. This competition landscape is a valuable part of the report as it contains all the necessary information to study the leading companies operating in the global hepatitis B diagnostic tests market in detail and also reveals how they implement their strategies and vision to stay at top in this highly competitive market.
Our robust research methodology always aims for maximum perfection
Overall market size has been analysed through historical data, primary responses, and public domain data. Revenue of companies in the global hepatitis B diagnostic tests market has been benchmarked to ascertain the market size for the base year. Macroeconomic indicators such as GDP and industry growth have been considered to forecast the market size over the forecast period. The historical growth trend of end-use industries, market participants’ performance, as well as the present macro-economic outlook has been taken into consideration for estimating the overall market trend forecast. This data is then validated using the triangulation method and is extensively scrutinised using advanced tools to garner quantitative and qualitative insights into the global hepatitis B diagnostic tests market.
By Product Type
By End User